Todas as categorias
| Product Name | Descrição | Action |
|---|---|---|
| Sacituzumab govitecan | Trade Name : Trodelvy Target : TROP-2 Molecular Type : ADC Sales in 2025 (Millions of USD) : 1014(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Risankizumab, Skyrizi, anticorpo bispecífico, BI 655066, inibidor da interleucina / inibidor da IL-23, imunologia biológica, anticorpo monoclonal, CAS n.o 1612838-76-2 | Trade Name : Skyrizi Target : Bispecific antibody Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 13000~15000(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tezepelumab, Tesspire, TSLP, Anticorpo monoclonal, AMG 157, Biológico anti-TSLP, Biológico respiratório / Biológico da asma, CAS n.o 1572943-60-0 | Trade Name : Tezspire Target : TSLP Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 826(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Dupilumab,Dupixent,REGN668,Inhibitor do receptor da interleucina,Inmunologia biológica,Anticorpo monoclonal,CAS n.o 1190264-60-8 | Trade Name : Dupixent Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1340(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Hialuronidase, Enzima / Enzima recombinante, Excipiente biológico / Componente de co-formulação biológica, Nº CAS 9001-54-1 | Trade Name : N/A Target : N/A Molecular Type : Enzymes Sales in 2025 (Millions of USD) : 1300~1375(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Etanercepte | Trade Name : Enbrel Target : N/A Molecular Type : Fusion Protein Sales in 2025 (Millions of USD) : 2300~2500(estimate) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Pertuzumabe, Perjeta, Phesgo, 2C4, Terapia direcionada anti-HER2, Biológico oncológico / Anticorpo para câncer de mama, Anticorpo monoclonal, Nº CAS 380610-27-5 | Trade Name : Perjeta Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 2800(First three quartersestimate ) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch ... |
|
| Tocilizumab,Actemra,RoActemra,MRA,R-1569,Inhibitor do receptor de interleucina,Biologia imunológica,Anticorpo monoclonal, CAS n.o 375823-41-9 | Trade Name : Actemra Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 1280(First half of the year) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
